Epitome Therapeutics

Epitome Therapeutics

HealthVienna, Austria

Epitome Therapeutics is a BioTech company focused on advancing precision epigenome editing for programmable gene expression. The company aims to develop new therapeutic approaches based on the precise regulation of gene expression, with a notable emphasis on their CADENCE platform. This funding will help them build their team and advance their development programmes.

$4.3M · Pre-seedVisit website ↗

Funding history

  1. $4.3MPre-seed2026-06-30
    Source: news.google.com ↗

Founder

Dr. Guido Gualdoni
Dr. Guido Gualdoni
Co-founder and CEO

Investors in Epitome Therapeutics

Backers from this company's tracked funding rounds.

  • XISTA Science Ventures
  • Caesar Ventures
  • Navec Venture Holding GmbH

More Health companies

Recently funded startups in the same category.

Related on Datapile